Viva Xt Crt-D
Payments companies reported to CMS as associated with Viva Xt Crt-D. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Viva Xt Crt-D, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Viva Xt Crt-D
These are the largest totals companies reported as associated with Viva Xt Crt-D. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Krishna Rocha Singh | Springfield, IL | Interventional Cardiology | $188.42 |
| Jeffrey Carr | Tyler, TX | Interventional Cardiology | $188.42 |
| Louis Lopez | Fort Wayne, IN | Cardiovascular Disease | $188.42 |
| Gary Ansel | Columbus, OH | Interventional Cardiology | $188.42 |
| Steven Okuhn | San Francisco, CA | Vascular Surgery | $188.42 |
| Ravish Sachar | Raleigh, NC | Interventional Cardiology | $188.42 |
| Alexander Ushinsky | Saint Louis, MO | Diagnostic Radiology | $188.42 |
| Sahil Parikh | New York, NY | Interventional Cardiology | $188.42 |
| Jose Martinez Ojeda | Orlando, FL | Interventional Cardiology | $188.42 |
| Nicolas Nelken | Honolulu, HI | Vascular Surgery | $188.42 |
Prescribed Viva Xt Crt-D?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.